Tackling therapeutic inertia: role of treatment data in quality indicators

Many patients with hypertension remain undertreated despite the apparent rosy picture given by doctors meeting current targets. Different measures are needed to overcome therapeutic inertia, argue Bruce Guthrie, Melanie Inkster, and Tom Fahey

[1]  Evangelos Kontopantelis,et al.  Pay-for-performance programs in family practices in the United Kingdom. , 2006, The New England journal of medicine.

[2]  E. Vittinghoff,et al.  Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus , 2006, Annals of Internal Medicine.

[3]  T Fahey,et al.  Adherence to antihypertensive medication and association with patient and practice factors , 2006, Journal of Human Hypertension.

[4]  P. Donnan,et al.  Organisational factors in relation to control of blood pressure: an observational study. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[5]  H. Mcdonald,et al.  Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. , 2005, JAMA.

[6]  Sarah Corley,et al.  A Multimethod Quality Improvement Intervention To Improve Preventive Cardiovascular Care , 2004, Annals of Internal Medicine.

[7]  J. Ensign.  Quality of health care: the views of homeless youth. , 2004, Health services research.

[8]  R. Hayward,et al.  Quality improvement initiatives: issues in moving from diabetes guidelines to policy. , 2004, Diabetes care.

[9]  Morris J. Brown,et al.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary , 2004, BMJ : British Medical Journal.

[10]  D. Berlowitz,et al.  Hypertension control: how well are we doing? , 2003, Archives of internal medicine.

[11]  T. Fahey,et al.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.

[12]  H. Hense,et al.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.

[13]  T. Lumley,et al.  Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[14]  R. Hayward,et al.  Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. , 2001, The American journal of managed care.

[15]  H. Black.  Clinical trials in hypertension , 2001 .

[16]  L. Poston,et al.  British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.

[17]  E. McGlynn,et al.  Part 2: Measuring Quality of Care , 1996 .

[18]  S. Shea,et al.  Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. , 1992, The New England journal of medicine.

[19]  Langford Hg.  The hypertension detection and follow-up program. , 1984 .